BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2015 8:51:00 AM | Browse: 365 | Download: 455
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 20739
Country/Territory United States
2015-06-19 08:39
Peer-Review Started
2015-06-20 17:19
To Make the First Decision
2015-07-27 18:35
Return for Revision
2015-07-31 17:11
2015-08-14 23:06
Second Decision
2015-09-10 08:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-09-18 14:16
Articles in Press
2015-09-18 14:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-10-26 15:13
Publish the Manuscript Online
2015-11-17 08:51
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Novel therapy for advanced gastric cancer
Manuscript Source Invited Manuscript
All Author List Yue Zhang and Shenhong Wu
Funding Agency and Grant Number
Corresponding author Yue Zhang, MD, MPH, Assistant Professor, Division of Hematology and Oncology, Stony Brook University, HSC 15-040, 101 Nicholls Rd, Stony Brook, NY 11794-8151, United States. yue.zhang@stonybrookmedicine.edu
Keywords Gastric cancer; Novel therapy; Targeted therapy; Immune therapy; Gastric cancer stem cell
Core Tip Advanced gastric cancer (GC) has very poor outcome with chemotherapy remains the main treatment. There is an urgent unmet need to develop novel therapy for GC. Limited success is achieved for targeted therapy after trastuzumab for human epidermal growth factor receptor 2 positive disease. Ramucirumab was recently approved by Food and Drug Administration as a single agent or combined with paclitaxel in refractory advanced GC patients. Immune therapy and GC stem cell research are on the horizon.
Publish Date 2015-11-17 08:51
Citation Zhang Y, Wu S. Novel therapy for advanced gastric cancer. World J Gastrointest Oncol 2015; 7(11): 263-270
Url http://www.wjgnet.com/1948-5204/full/v7/i11/263.htm
DOI http://dx.doi.org/10.4251/wjgo.v7.i11.263
Full Article (PDF) WJGO-7-263.pdf
Full Article (Word) WJGO-7-263.doc
Manuscript File 20739-Review.docx
Answering Reviewers 20739-Answering reviewers.pdf
Audio Core Tip 20739-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 20739-Conflict-of-interest statement.pdf
Copyright License Agreement 20739-Copyright assignment.pdf
Peer-review Report 20739-Peer-review(s).pdf
Scientific Misconduct Check 20739-Scientific misconduct check.pdf
Scientific Editor Work List 20739-Scientific editor work list.pdf